- OUTLOOK
The promise and pitfalls of gene testing for cancer risk

Illustration by Antoine Dore
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 600, S50-S52 (2021)
doi: https://doi.org/10.1038/d41586-021-03720-y
This article is part of Nature Outlook: Ovarian cancer, an editorially independent supplement produced with the financial support of third parties. About this content.
References
Hao, J. et al. J. Pers. Med. 10, 7 (2020).
Chlebowski, R. T. et al. JAMA 324,369–380 (2020).
Kurian, A. W. et al. J. Clin. Oncol. 37, 1305–1315 (2019).
Kurian, A. W. et al. J. Clin. Oncol. 39, 1631–1640 (2021).